Peter Van Vlasselaer
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 7
- Reproductive System and Pregnancy 5
- T-cell and B-cell Immunology 5
- Immunology and Allergy top 5%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 15
- CAR-T cell therapy research 14
- Genetics top 10%
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Cancer Research and Treatments 4
Peter Van Vlasselaer
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Immunology 779
- Immunology and Allergy 168
- Oncology 341
- Genetics 97
- Physiology 186
Countries citing papers authored by Peter Van Vlasselaer
This map shows the geographic impact of Peter Van Vlasselaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Van Vlasselaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Van Vlasselaer more than expected).
Fields of papers citing papers by Peter Van Vlasselaer
This network shows the impact of papers produced by Peter Van Vlasselaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Van Vlasselaer. The network helps show where Peter Van Vlasselaer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Van Vlasselaer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 1 | |
| 2 | 2017 | 1 | |
| 3 | 2017 | 1 | |
| 4 | 2017 | 3 | |
| 5 | 2017 | 1 | |
| 6 | 2017 | 1 | |
| 7 | 2016 | 7 | |
| 8 | 2015 | 25 | |
| 9 | 2000 | 1 | |
| 10 | 1999 | 3 | |
| 11 | 1996 | 10 | |
| 12 | 1995 | 18 | |
| 13 | Decreased acquisition of osteoblastic phenotype markers and increased response to interleukin-1 and parathyroid hormone in pre-osteoblast like cells under microgravity | 1994 | 1 |
| 14 | 1994 | 23 | |
| 15 | 1992 | 40 | |
| 16 | 1992 | 14 | |
| 17 | 1992 | 30 | |
| 18 | 1991 | 4 | |
| 19 | 1991 | 8 | |
| 20 | 1991 | 43 |
About Peter Van Vlasselaer
Peter Van Vlasselaer is a scholar working on Immunology, Oncology and Biotechnology, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (7 papers), Reproductive System and Pregnancy (5 papers), T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Immunology (779 citations), Immunology and Allergy (168 citations) and Oncology (341 citations). Peter Van Vlasselaer has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include J E de Vries, Juha Punnonen, René de Waal Malefyt, Hugues Gascan, Gregorio Aversa, J F Gauchat, Jean‐François Gauchat, N. Falla, Éric Mathieu and Hans‐Willem Snoeck. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Cell Biology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.